Views: 0 Author: Site Editor Publish Time: 2026-05-06 Origin: Site
We are beyond excited to announce that on May 6, 2026 - Cofoe Medical Technology Co., Ltd. officially went public on the Main Board of the HongKong Stock Exchange (stock code: 01187.HK)!
✨Already listed in Mainland China (SZSE: 301087) since 2021, we have now achieved a dual listing in both Mainland China and Hong Kong - a MASSIVE leap toward our global future!
After nearly 20 years of dedication to home medical devices, we are now ready to serve the word from a stronger, international capital platform.
And we're starting strong: Q1 2026 results
▪️ Revenue: RMB 1.012 billion (+37% vs. last year)
▪️ Recurring Net Profit: RMB 94 million (+37% vs. last year)
2025 was already a record year: RMB 3.387B revenue, #1 market share in rehabilitation aids in China, and overseas revenue growth of over 400%!
Innovation that makes a difference
We are now an R&D powerhouse – creating smarter, warmer, more accessible medical technologies:
World's first one-drop blood test for both glucose & uric acid
Cofoe AI Research Institute + in-house LLM (Large Language Model) coming soon
C11 smart ventilator – as quiet as 23dB for better sleep
AI bone-conduction hearing aids (with Tencent Tianlai) – world-class clarity at 1/5 the cost of imports
Going global, fast
▪️ Acquired Shanghai Huazhou & Hong Kong Humana → filled our channel map in Europe, US, and Southeast Asia.
▪️ Partnered with Royal Philips → exclusive rights to 7 core categories in Greater China. A true fusion of global brand and smart Chinese manufacturing.
This is the beginning. The best is yet to come!!!
